SUCLG2 and colorectal carcinoma: To further ascertain the contribution of Gln-derived α-KG–mediated replenishment of the TCA cycle to the effects of SLC25A21, we inhibited the conversion of α-KG into succinate via an siRNA targeting SUCLG2 in SLC25A21-depleted CRC cells.